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Background: To evaluate the efficacy and patient satisfaction of laser in situ keratomileusis 
(LASIK) monovision correction in presbyopic emmetropic patients.
Methods: A retrospective review of 294 patients who underwent LASIK for monovision 
was conducted. All patients had preoperative uncorrected distance visual acuity in each eye of 
20/25 or better in both eyes and underwent primary LASIK treatment in one eye with a near 
target; 82 patients underwent surgery in the distant eye for hypermetropia. Patients completed 
a patient-reported-outcome questionnaire at their one-month postoperative visit. Analysis was 
performed on a per patient basis with a logistic regression model.
Results: Patients achieved a postoperative mean spherical equivalent of -0.05 diopters (D) in 
the distant eye and -1.92 D in the near eye. Prior to surgery, 64.7% (n=178) of patients reported 
they were satisfied or very satisfied with their vision; postoperatively, this increased to 85.4% 
(n=251). The greatest predictor of dissatisfaction after surgery was severe patient-reported visual 
phenomena (glare, halos, starbursts, ghosting) (odds ratio 1.18, P=0.001).
Conclusions: LASIK monovision for presbyopic patients with low refractive error and good 
preoperative uncorrected distance visual acuity is both safe and effective with high patient 
satisfaction. Patients who were dissatisfied in the postoperative period tended to be those with 
postoperative visual symptoms.
Keywords: monovision, LASIK, presbyopia, refractive surgery
Background
The treatment of presbyopia remains a challenge in refractive surgery. Numerous 
surgical options exist, including monovision from laser-assisted in situ keratomileu-
sis (LASIK) or photorefractive keratectomy; corneal inlays;1 multifocal2 or aspheric 
corneal ablation;3 and refractive lens exchange with a multifocal, accommodating or 
extended depth of focus intraocular lens.4 Monovision with LASIK has been shown to 
be a safe and effective means of treating presbyopia with high patient satisfaction.5–7
Presbyopic correction in emmetropic or low hypermetropic patients requires 
particular attention, as patients have had good uncorrected vision prior to presbyopia 
and thus carry high expectations. A few studies have been performed regarding the 
use of LASIK monovision in emmetropes; however, they indicate promising results 
with regard to effectiveness and patient satisfaction.3,7–9 In this study, we assess the 
visual and patient-reported outcomes of emmetropic patients who underwent LASIK 
specifically for monovision to treat presbyopia.
Methods
This retrospective study was reviewed and approved by the Committee on Human 
Research, the institution-specific name for Institutional Review Board at the University 
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of California, San Francisco. It was deemed exempt from 
review as it contained only de-identified information. This 
work is compliant with the Health Insurance Portability and 
Accountability Act of 1996 and has adhered to the tenets of 
the Declaration of Helsinki. All patients provided informed 
consent to undergo refractive surgery, but consent for partici-
pation was not sought as this study only used retrospective, 
de-identified data.
The records of Optical Express (Glasgow, UK), a large 
provider of refractive surgical services, were searched to 
identify all cases between January 1, 2012, and December 31, 
2015, that met the following criteria: patients aged 45 or older 
who underwent primary LASIK treatment with an uncorrected 
distance visual acuity of 20/25 or better, underwent monovi-
sion treatment with a target of at least -1.0 D (diopters) in the 
near eye, attended a one-month follow-up visit and completed 
a patient-reported-outcome (PRO) questionnaire.
Data on demographic information (date of birth, gender, 
dominant eye), preoperative and postoperative refractive 
error (manifest refraction, uncorrected distance visual acuity 
[Snellen visual acuity chart]), uncorrected near reading acuity 
(measured with a logarithmic Bailey–Lovie near reading 
chart), best-corrected visual acuity (BCVA), keratometry 
(Pentacam, Oculus, Inc., Arlington, WA), the use of con-
tact lens trial, preoperative and postoperative PRO, date of 
surgery and laser treatment were obtained.
All patients desired improved near vision without optical 
aids and met the indications for laser vision correction as 
specified by the excimer laser user manual (VISX Star S4, 
Abbott Medical Optics, Santa Ana, CA) with the exception 
that patients with autoimmune disease could undergo surgery 
if their condition was stable and well controlled. The patients 
provided full informed consent for LASIK surgery. All abla-
tions were performed on the VISX Star S4 laser using a stan-
dard, wavefront-guided or iDesign ablation. All flaps were 
created with the Intralase iFS (Abbot Medical Optics).
Patients who expressed interest in monovision received 
a monovision trial with trial frames in clinic. If they liked 
this monovision trial, then they were scheduled thereafter for 
surgery. Patients who were unsure underwent a contact lens 
monovision trial prior to surgery. A near target was selected 
for their nondominant eye unless they preferred near vision 
in the dominant eye with a monovision demonstration.
The PRO provided was based on the questionnaire offered 
to patients in the Patient Reported Outcomes with LASIK 
(PROWL) trials.10 The survey was self-administered in a 
private kiosk in the clinic, and patients were assured that all 
the information would remain anonymous and the results 
would not be shared with their treating physician or be used 
to inform their care. All response fields used a Likert scale 
to obtain the patient’s preferences or degree of agreement. 
The incidence of visual phenomena, such as starburst, halo, 
glare, and ghost images/double vision, was rated on a scale 
between 1 (no difficulty) and 7 (severe difficulty). Ability 
to perform activities of daily living, including hobbies, driv-
ing and sports, was also assessed from 0 (no difficulty) to 
4 (severe difficulty), with an option to indicate that patients 
did not partake in these activities for other reasons.
Descriptive statistics were obtained using Excel (Micro-
soft, Redmond, WA, USA). For the safety analysis, only 
patients with a recorded month-1 refraction and best-corrected 
distance acuity were included. For nonparametric data, aver-
ages are reported as the mean with the interquartile range 
(IQR), or the distribution between the 25th and 75th percen-
tiles. For dichotomous outcomes (satisfied vs dissatisfied), 
Pearson’s chi-squared test was used for significance. Analysis 
was conducted using the Stata software package (STATA-
Corp, College Station, TX, USA) and on a per-patient basis. 
A univariate logistic regression model was fitted into the 
data, and odds ratios (ORs) for patient dissatisfaction were 
calculated. Factors with a P-value of #0.1 from the univariate 
model were utilized to construct a multivariate model.
Results
Two hundred and ninety-four patients were identified, includ-
ing 134 females (45.6%), with an average age of 52.5±4.5 
years (Table 1). One hundred and sixty-nine of these patients 
(57.5%) trialed monovision with contact lenses prior to their 
LASIK procedure; the remainder trialed monovision in clinic 
and found it acceptable or had been using monovision in 
their habitual correction. Eighty-two patients (27.9%) also 
underwent LASIK for the distant eye for hypermetropia, 
with a good preoperative uncorrected acuity but symptoms 
Table 1 Demographic information
Total participants 294 patients
Female 134 (45.6%)
age 52.5±4.50 years
Follow-up 30 days±7 days
Dominant/nondominant eyes 9 (3.1%)/285 (96.9%)
Contact lens trial 169 (57.5%)
Ablation profile
standard 144 (48.9%)
Wavefront-guided 21 (7.14%)
iDesign 129 (43.9%)
Note: 82 patients underwent lasiK in the distance eye for hypermetropia.
Abbreviation: lasiK, laser-assisted in situ keratomileu sis.
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Table 2 Preoperative and postoperative refraction and acuity data
Measurement Distant eye Near eye
Preoperative, n=80 Postoperative, n=80 Preoperative, n=294 Postoperative, n=294
sphere (D)
Mean ± sD
(range: Min, Max)
+0.96±0.51
(-0.75 to +2.00)
+0.04±0.30
(-0.75 to +1.00)
+0.59±0.50
(-0.75 to +2.00)
-1.76±0.70
(-4.25 to +1.25)
Cylinder (D)
Mean ± sD
(range: Min, Max)
-0.45±0.46
(-2.75–0.00)
-0.32±0.32
(-1.50–0.00)
-0.35±0.32
(-1.75–0.00)
-0.46±0.6
(-1.50–0.00)
Mse (D)
Mean ± sD
(range: Min, Max)
+0.73±0.57
(-1.625 to +1.75)
-0.05±0.30
(-0.875 to +0.75)
+0.41±0.48
(-1.25 to +1.75)
-1.92±0.71
(-4.63 to +1.00)
Monocular UCVaa (logMar)
Mean ± sD
(range: Min, Max)
0.05±0.07
(-0.08–0.1)
-0.03±0.11
(-0.18–0.4)
-0.004±0.08
(-0.18–0.1)
0.66±0.24
(-0.08–1.3)
Monocular UCnaa (logMar)
Mean ± sD
(range: Min, Max)
0.75±0.27
(0–1.6)
– 0.73±0.27
(0–1.6)
0.18±0.16
(-0.1–0.9)
Monocular CDVab (logMar)
Mean ± sD
(range: Min, Max)
-0.08±0.04
(-0.18–0)
-0.07±0.05
(-0.18–0.10)
-0.07±0.04
(-0.18–0)
-0.04±0.10
(-0.18–0.9)
Notes: aUncorrected distance visual acuity (UCDVa) and uncorrected near visual acuity (UCna) for near eyes and distance for distance eyes. bMonocular spectacle-
corrected distance visual acuity (CDVa).
Abbreviations: logMar, log minimum angle of resolution; Mse, manifest spherical equivalent; Min, minimum; Max, maximum.
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Figure 1 Preoperative and postoperative uncorrected near acuity of eyes in patients 
who underwent near lasiK correction.
Note: Visual acuity was 20/40 or better in 88.9% (n=184) after surgery as compared 
to 4.7% (n=9) preoperatively.
Abbreviation: lasiK, laser-assisted in situ keratomileu sis.
of eyestrain when not wearing correction. Near eye treat-
ment was performed in the right eye in 165 patients (56.1%). 
The near target range ranged from -1 to -2.25, with a mean 
of -1.48 (IQR 0.3). Postoperative refraction and acuity data 
for treated near and distance targets are outlined in Table 2.
In patients with recorded postoperative near reading 
acuity, near acuity improved to 20/40 or better in 88.9% 
(n=184 of 207 patients with recorded near acuity) as com-
pared to 4.7% (n=9) preoperatively (Figure 1). The final 
uncorrected distance visual acuity (UCDVA) in the distant 
eye (including both treated and untreated eyes) was 20/20 
or better in 89.8% (n=265) and 20/25 or better in 98.3% 
(n=289). Of the 273 near eyes for which BCVA was avail-
able at one month, 1.1% (n=3) of patients gained $2 lines 
of best-corrected acuity, 6.2% (n=17) gained 1 line, 66.3% 
(n=181) had no change, 32.2% (n=88) lost 1 line, and 0.7% 
(n=2) lost $2 lines. Of those patients who lost two or more 
lines, one lost two lines and one lost three lines, with a final 
BCVA of 20/32 in both cases. Both patients reported they 
were satisfied with their vision at one month.
Preoperatively, 221 of 294 patients (75.2%) answered ques-
tions pertaining to visual satisfaction, and all patients answered 
at month 1. Preoperatively, 64.7% (n=143) of patients reported 
they were satisfied or very satisfied with their vision. Postop-
eratively, 85.4% (n=251) of patients reported they were satis-
fied or very satisfied with their vision (Figure 2), an increase 
that was statistically significant (P=0.001). Eighty-nine percent 
(n=262) of patients would recommend the experience, 84.0% 
(n=247) felt that it improved their life and 87.8% (n=258) 
stated that they would have the procedure again.
Patients answered questions pertaining to their level 
of difficulty with driving, sports and hobbies (Figure 3). 
There was an increase in reported difficulty with driv-
ing from preoperatively to postoperatively, with 86.0% 
(n=194) reporting little to no difficulty with driving preop-
eratively and 71.1% (n=209) reporting little to no difficulty 
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postoperatively, P,0.001. The reverse was true for hobbies 
and sports, with more patients reporting little to no difficulty 
postoperatively than preoperatively (P,0.001 for both).
Patients reported an increase in visual symptoms in all 
four categories postoperatively as compared to preoperatively 
(Table 3). Preoperatively, only two patients reported any 
severe or very severe visual symptoms, whereas 60 patients 
reported at least one severe or very severe symptom post-
operatively (P,0.001).
A logistic regression was performed to determine whether 
there were any significant factors related to patient dissatis-
faction after surgery. In the univariate model, preoperative 
uncorrected near acuity, postoperative MSE, postoperative 
dry symptoms and postoperative visual symptoms were 
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Figure 2 Patient-reported satisfaction with vision before and after undergoing 
surgery.
Note: Postoperatively, 85.4% (n=251) of patients reported they were satisfied or 
very satisfied with their vision (P=0.001).
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Figure 3 Patient satisfaction with driving and activities of daily living.
Notes: (A) Patient-reported ability with driving before and after surgery. eighty-six percent of patients (n=194) reported little to no difficulty with driving preoperatively vs 
71.1% (n=209) postoperatively (P,0.001). (B) Patient-reported ability to perform distance activities of daily living (before and after surgery). More patients reported little 
to no difficulty postoperatively than preoperatively (P,0.001). (C) Patient-reported ability to perform near activities of daily living before and after surgery. More patients 
reporting little to no difficulty postoperatively than preoperatively (P,0.001).
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significantly related to patient satisfaction (Table 4). In the 
multivariate model (Table 5), only postoperative visual 
symptoms were significant (OR for dissatisfaction 1.18 for 
every unit increase in visual symptoms score, P=0.001). 
Postoperative MSE in the near eye correlated with visual 
symptoms (correlation coefficient =-1.85, 95% CI -2.75 
to -0.95, P,0.001); however, in the multivariate model, 
only visual symptoms were a significant predictor of postop 
dissatisfaction. Ninety-eight percent (n=96) of patients who 
reported zero visual symptoms were satisfied as compared 
with 0% (n=6) of patients who reported severe symptoms 
in all categories (Figure 4). There were no other significant 
relationships with other factors analyzed, including preopera-
tive visual satisfaction, preoperative visual symptoms, pre-
operative dry eye, preoperative and postoperative refraction 
and change in refraction. There was no correlation between 
age or near target and patient dissatisfaction with vision 
(P.0.5 for both).
Discussion
Presbyopia remains a significant challenge in refractive 
surgery. Although there are many new options for treatment, 
including corneal inlays and refractive lens exchange with 
multifocal or accommodating IOLs, monovision remains the 
treatment with the longest track record.11–13 More specifically, 
LASIK monovision has been shown to be safe and efficacious; 
however, there seems to be some tradeoff of the extended 
range of vision for stereo acuity and contrast acuity.14
In this study, we investigated monovision LASIK specifi-
cally in emmetropic presbyopic patients. These patients had 
excellent uncorrected visual acuity and underwent LASIK with 
the goal of treating their presbyopia. As these patients were either 
emmetropic or mildly hyperopic, all treatments performed in 
this study were hyperopic treatments. Hyperopic treatments 
have been shown to be less reliable than myopic treatments, 
but they match the visual and safety outcomes reported here.15
This patient cohort is one of the most demanding that a 
refractive surgeon will encounter in their practice, and in this 
study did well with good refractive results and high levels of 
satisfaction. Previous studies have similarly shown increased 
postoperative satisfaction with presbyopic correction in 
Table 3 average (±sD) preoperative and postoperative patient-reported visual symptoms
Any symptom
N patients (%)
Glare Halos Starbursts Ghosting
Preop average score n=209 105 (50.2%) 0.32±0.8 0.22±0.7 0.28±0.7 0.22±0.7
Postop average score n=294 193 (65.6%) 1.50±1.6 1.34±1.7 1.43±1.7 0.86±1.4
Change – 1.21±1.9 1.10±1.8 1.13±1.9 0.69±1.6
severe symptoms n patients (%)
Preop 2 (0.9%) 1 (0.5%) 0 (0%) 0 (0%) 1 (0.5%)
Postop 60 (20.4%) 19 (6.5%) 20 (6.8%) 30 (10.2%) 14 (4.8%)
Notes: symptoms were reported on a likert scale of 0–6, with zero being no symptoms and six being very severe symptoms. The number here represents the average score 
for all patients before and after surgery, as well as the average change in symptoms. Severe symptoms were defined as a score of 5 or 6 on the scale.
Table 4 Univariate analysis of factors related to postoperative 
dissatisfaction with vision
Variables Odds ratio 95% CI P-value
age 0.99 0.90–1.10 0.9
gender
Male (reference)
Female
1
2.21
–
0.83–5.85
–
0.1
Preop visual satisfaction
Dissatisfied (ref)
neutral
Satisfied
1
0.46
0.51
–
0.15–1.73
0.10–2.21
–
0.3
0.3
Preop visual symptom score 0.80 0.52–1.22 0.3
Preop UCDa (logMar) 1.41 0.01–308 0.9
Preop dry score 0.44 0.14–1.40 0.2
Preop Mse 1.36 0.53–3.48 0.5
Preop UCna 0.14 0.02–1.02 0.05
Postop Mse 0.38 0.21–0.70 0.002
Postop UCna 4.87 0.21–113 0.9
Postop dry score 1.64 1.25–2.18 ,0.001
Postop visual complaints 1.24 1.15–1.34 ,0.001
Monovision target 0.57 0.11–3.08 0.5
Note: Statistically significant values shown in bold.
Abbreviations: logMar, log minimum angle of resolution; Mse, manifest spherical 
equivalent; UCDa, uncorrected distance visual acuity; UCna, uncorrected near 
visual acuity.
Table 5 Multivariate analysis of factors related to postoperative 
dissatisfaction with vision
Variables Odds ratio 95% CI P-value
gender
Male (reference)
Female
1
1.95
–
0.62–6.11
0.3
Preop UCna 0.11 0.01–1.12 0.06
Postop Mse 0.54 0.26–1.13 0.1
Postop dry score 1.26 0.88–1.79 0.2
Postop visual symptoms score 1.18 1.07–1.29 0.001
Note: Statistically significant values shown in bold.
Abbreviations: Mse, manifest spherical equivalent; UCna, uncorrected near visual 
acuity.
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emmetropes.16–18 We found that 85% of patients were satisfied 
with their vision at 1 month as compared to 65% preopera-
tively and found an increase in near acuity to 20/40 or better 
in 89.8% of patients. Patients reported an increased ability 
to play sports and perform near work in hobbies.
We also found an increase in patient-reported difficulty 
with driving, as well as an increase in visual phenomena, 
including glare, halos, starbursts and ghosting. Patients who 
experienced these symptoms were more likely to report 
dissatisfaction with their vision than those who did not. 
Unfortunately, there were no preoperative predictors of 
patient dissatisfaction that we found that might be used to 
screen patients more likely to end up unhappy. However, the 
number of patients dissatisfied with their vision was small 
(21 patients), which likely hampered our ability to find sig-
nificant contributors.
Interestingly, a significant number of patients (46.5%) 
opted to not undergo a contact lens trial prior to undergo-
ing monovision. We found no correlation between having 
undergone a contact lens trial and postoperative patient 
satisfaction, indicating that a trial may not always be neces-
sary prior to surgery. This is similar finding to that of Reilly 
et al, who found no correlation between a contact lens trial 
and desire for reversal of monovision.19 However, as this is a 
retrospective study, it is possible that some of these patients 
had previously undergone a monovision and therefore opted 
out, which would not have been captured in this dataset.
The increase in visual symptoms as well as driving dif-
ficulty that we saw may be attributable to either the imbal-
ance induced by the monovision correction or inherent to 
the hyperopic LASIK procedure itself. A previous study 
compared visual symptoms after monovision LASIK in 
myopic and hyperopic patients, and found hyperopic patients 
Figure 4 Patient satisfaction as a function of visual symptom score.
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had more visual symptoms than their myopic counterparts.20 
Data on patient-reported visual symptoms after hyperopic 
LASIK are scant. The PROWL studies included hyperopes, 
but these were a very small percentage of the entire cohort 
and a specific subanalysis was not conducted.10 It has been 
described that monovision decreases stereo acuity and low-
contrast vision,14 with an effect that increases with increasing 
refractive difference between the eyes.21 A direct comparison 
with monovision LASIK in myopic eyes would thus be useful 
in elucidating the source of these symptoms.
Limitations of this study include its retrospective nature 
and short follow-up. The PROWL-1 study demonstrated a 
decrease in visual phenomena between the three- and six-
month visits and did not include a one-month time point of 
evaluation.10 It is possible that those patients in this study 
may have an improvement in bothersome visual phenomena 
or neuroadaptation to monovision with time, as has been 
previously demonstrated.22,23
Conclusion
We present a large retrospective study of LASIK monovision 
for presbyopic correction in a population of emmetropes, 
which demonstrates procedural safety and visual success. 
Postoperative symptomatology was shown to be associated 
with overall procedural dissatisfaction.
Data availability
Data are available upon reasonable request to the correspond-
ing author.
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